IS THERE A CONNECTION BETWEEN PYLORIC HELICOBACTER INFECTION AND METABOLIC DISORDERS?

Abstract


Relevance. There are numerous publications of foreign authors about relationship between Pyloric Helicobacter (H. p.) infection with several gastroduodenal diseases, including metabolic disorders. Russia is one of the countries with high prevalence of H. p. infection and metabolic disorders. Determining their relationship is important for both prevention and treatment of metabolic disorders. Purpose - study the possibility of relationship between H. p. infection and type 2 diabetes, dyslipidemia, overweight and obesity. Methods and materials. The study included 1487 working residents of Moscow and the Moscow region, 931 men and 556 women, aged 21 to 77 years (median - 46). H. p. infection was diagnosed by detecting antibodies to IgG bacteria in the blood serum. In 698 infected individuals, the presence of a CagA strain, a marker of virulence of the bacterium, was studied using ELISA. Serum levels of basal glucose, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides were studied, and the body mass index was determined. Results. Infection was discovered in 1348 people (90.6%), CagA positive - 392 (56.2%). Type 2 diabetes was diagnosed in 77 people, 74 - H. p. positive (5.5% ), and 3 - H. p. negative (2.1%). CagA was studied for 31 persons with diabetes. CagA-positive bacterial strain was determined in 22 cases out of 31 (70.1%, p <0,05 by criterion χ²). Dyslipidemia was detected in 175 persons (11.8%), 165 persons H. p. positive (12.2%), 10 - H. p. negative (7.2%) (p>0,05, by criterion χ²). Among H. p. positive, overweight was registered in 884 cases (65.6%), in H. p. negative - in 74 cases (53.2%) (p<0,05 by criterion χ²). Conclusion. In the presence of H. p. infection, the prevalence of metabolic abnormalities increases, which indicates a possible connection between them.

Full Text

Restricted Access

About the authors

Serafima V. German

Center of Strategic Planning and Management of Medical and Biological Health Risks

Email: svgerman@yandex.ru
119992, Moscow, Russian Federation
doctor of medical sciences, Leading research scientist, Laboratory of ecological physiology, biological climatology and Arctic medicine, Center of Strategic Planning and Management of Medical and Biological Health Risks, 129110, Moscow, Russian Federation

A. V Modestova

N.I. Pirogov Russian National Research Medical University

117997, Moscow, Russian Federation

I. E Zykova

Center of medico-biological and ecological problems of RAEN

117638, Moscow, Russian Federation

I. G Nikitin

N.I. Pirogov Russian National Research Medical University

117997, Moscow, Russian Federation

References

  1. Решетников О.В., Курилович С.А., Кротов С.А., Кротова В.А. Мониторинг инфекции, вызываемой Helicobacter pylori в Новосибирске. Журнал микробиологии, эпидемиологии, иммунобиологии. 2008; 1: 99-100.
  2. Герман С.В., Зыкова И.Е., Ермаков Н.В., Модестова А.В. Распространенность инфекции Н. pylori среди населения Москвы. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2010; 2: 25-30.
  3. Дедов И.И., Шестакова М.В., Викулова О.К. Эпидемиология сахарного диабета в Российской Федерации: клинико-статистический анализ по данным Федерального регистра сахарного диабета. Сахарный диабет. 2017; 20(1): 13-41. doi: 10.14341/DM201535-22
  4. Vaarala O., Yki-Jarvinen H. Diabetes: Should we treat infection or inflammation to prevent T2D? Nat Rev Endocrinol. 2012; 8: 323-5.
  5. Simon L., Tornoczky J., Toth M., Jambor M., Sudar Z. The significance of Campylobacter pylori infection in gastroenterologic and diabetic practice. Orv Hetil. 1989; 130: 1325-9.
  6. Jeon C.Y., Haan M.N., Cheng.C., Clayton E.R., Mayeda E.R., Miller J.W., Aiello A.E. Helicobacter pylori infection is associated with an increased rate of diabetes. Diabetes Care. 2012; 5(3): 520-5. doi: 10.2337/dc11-1043
  7. Zhou X., Zhang C., Wu J., Zhang G. Association between Helicobacter pylori infection and diabetes mellitus : a meta-analysis of observational studies. Diabetes Res Clin Pract. 2013; 99: 200-8. doi: 10.1016/j.diabres.2012.11.012
  8. Yang G.H., Wu J.S., Yang Y.C,. Huang Y.H., Lu F.H., Chang C.J. Gastric Helicobacter pylori infection associated with risk of diabetes mellitus, but not prediabetes. J Gastroenterol Hepatol. 2014; 29: 1794-9. doi: 10.1111/jgh.12617
  9. Bajaj S., Rekwal L., Misra S.P., Misra V., Yadav R.K., Srivastava A. Association of Helicobacter pylori infection with type 2 diabetes. Indian J Endocrinol Metab. 2014; 18: 694-9.
  10. Franceshi F., Gasbarrini A., Polyzos S.A., Kountouras J. Extragastric diseases and Helicobacter pylori. Helicobacter. 2015; 20(S1): 40-6. doi: 10.1111/hel.12256
  11. Tsay F-W., Hsu P-I. H. pylori infection and extra-gastroduodenal diseases. J Biomed Sci. 2018; 25: 65.
  12. Ibrahim A., Zaher T., Ghonemy T.A., El-Azim S.A., El-Azim M.A., Ramadan A. Impact of cytotoxin-associated gene A of Helicobacter pylori strains on microalbuminuria in type 2 diabetes. Saud J Kidney Dis Transpl. 2010; 21(4): 694-700. doi: 10.4314/ajnt.v3i2.58892
  13. Buzas G.M. Metabolic consequences of Helicobacter pylori infection and eradication. World J Gastroenterol. 2014; 20(18): 5226-34. Doi: 10.3748wjg.v20.i18.5226
  14. Marietti M., Gasbarrini A., Saracco G., PellicanoR. Helicobacter pylori infection and diabetes mellitus: the 2013 state of art. Panminerva Med. 2013; 55(3): 277-81.
  15. Oluyemi A., Anomneze E., Smith S., Fasanmade O. Prevalence of a marker of active Helicobacter pylori infection among patients with type 2 diabetes mellitus in Lagos, Nigeria. BMC Res Notes. 2012; 5: 84. doi: 10.1186/1756-0500-5-284
  16. Sotuneh N., Hosseini S.R., Shokri-Shiravi J., Bijani A., Ghadimi R. Helicobacter pylori infection and metabolic parametrs: is there association in elderly population? Int J Prev. 2014; 5(12): 1537-52.
  17. Niemelä S., Kartiunen T., Korhonen H., Läärä H., Kartiunen R., Ikäheimo M., Kesäniemi Y.A. Could Helicobacter pylori infection increase the risk of coronary artery disease by modifying serum lipid concentration? Heart. 1996; 75: 573-5.
  18. Sharnagl H., Kist M., Grawitz A.B., Koenig W., Wieland H., Marz W. Effect of Helicobacter pylori eradication on high-density lipoprotein cholesterol. Am J Cardiol. 2004; 93: 219-20.
  19. Satoh H., Saiyo Y., Yoshioka E., Tsutsui H. Helicobacter pylori infection is a significant risk for modified lipid profile in Japanese male subjects. J Atheroscler Thromb. 2010; 17: 1041-8.
  20. Kim H.-L., Jeon H.H., Park I.Y., Choi J.M., Kang J.S., Min K.-W. Helicobacter pylori infection is associated with elevated low density lipoprotein cholesterol levels in elderly Koreans. J Korea Med Sci. 2011; 26(5): 654-8. doi: 10.3346/jkms.2011.26.5.654
  21. Nam S.Y., Ryu K.H., Park B.J., Park S. Effects of Helicobacter pylori infection and its eradication on lipid profiles and cardiovascular diseases. Helicobacter. 2014; 20(2): 125-32. doi: 10.1111/hel.12182
  22. Gravina A.G., Zagari R.M., De Musis C., Romano L., Loguerzio C., Romano M. Helicobacter pylori and extragastric diseases: A review. World J Gastroenterol. 2018; 24(29): 3204-21.
  23. Chen T.P., Hung H.F., Chen M.K., Lai H.H., Hsu W.F., Huang K.C., Yang K.C. Helicobacter pylori infection is positively associated with metabolic syndrome in Taiwanese adults: A crosssectional study. Helicobacter. 2015; 20: 184-91.
  24. Sotuneh N., Hosseini S.R., Shokri- Shirvani J., Bijani A., Ghadimi R. Helicobacter pylori infection and metabolic parameters: is there an association in elderly population? Int J Prev Med. 2014; 5(12): 1537-42.
  25. Cho I., Blaser M.J., Francois F., Mathew J.P., Ye X.Y., Goldberg J.D. Helicobacter pylori and overweight status in the United States. Data from the third national health and nutrition examination survey. Am J Epidemiol. 2005; 162: 579-84.
  26. Wu M.S., Lee W.J., Wang H.H., Huang S.P., Lin J.T. A case-control study of association of Helicobacter pylori infection with morbid obesity in Taiwan. Arch Intern Med. 2005; 165: 1552-5.
  27. Lender N., Talley N.J., Enck P., Haag S., Zipfel S., Morrison M., Holtmann G.J. Review article:associations between Helicobacter pylori and obesity - an ecological study. Alimentary Pharmacology and Therapeutics. 2014; (40)1: 24-31.
  28. Arslan E., Atilgan H., Yavasoglu I. The prevalence of Helicobacter pylori in obese subjects. Eur J Intern Med. 2009; 20: 695-7.
  29. Yang G.H., Wu J.S., YangY,C,. Huang Y.H., Lu F.H., Chang C.J. Obesity associated with increased risk of gastric Helicobacter pylori infection in an elderly Chinese population. J Am Geriatrics Society. 2014; 62: 190-2.
  30. Zhang V., Du T., Chen Xi, Yu X., Tu L., Zhang C. Association between Helicobacter pylori infection and overweight or obesity in a Chinese population. J Infect Dev Ctries. 2015; 9(9): 945-53.
  31. Chen L.W., Kuo S.F., Chen C.H., Chien C H., Lin C.L., Chien R.N. A community-based study on the association between Helicobacter pylori infection and obesity. Sci Rep. 2018; 8(11): 10746. doi: 10.1038/41598-018-28792.
  32. Kopacova M., Bures J., Koupil I., Rejchrt S., Vorisek V., Seifert B. Pozler O., Zivny P., Douda T., Palicka V., Holcik J. Body indices and basic vital sings in Helicobacter pylori positive and negative persons. Eur J Epidemiol. 2007; 22(1): 67-75. doi: 10.1007/s10654-006-9090-1

Statistics

Views

Abstract - 22

PDF (Russian) - 0

Cited-By


Article Metrics

Metrics Loading ...

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies